SMTL ID : 6tcq.1

Crystal structure of the omalizumab Fab Ser81Arg and Gln83Arg light chain mutant

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

hetero-1-1-mer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 11 residues within 4Å: Chain A: F.174, P.175, V.177, S.185, L.186, S.187 Chain B: Q.164, S.166, S.180, S.181, T.182 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:Q.164, B:S.166, A:P.175, A:S.187 Water bridges: B:T.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mitropoulou, A.N. et al., Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization. Acta Crystallogr.,Sect.F (2020)

Release Date

2020-03-18

Peptides

Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant: A
Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant

Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant

Related Entries With Identical Sequence